PUNT PEDIATRIC CANCER COLLABORATIVE INC (EIN 208533395) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Phone

7162003458

Tax Period

2023-01-01 to 2023-12-31

PUNT PEDIATRIC CANCER COLLABORATIVE INC, founded in 2007, is a community nonprofit in the Health Care sector that reported $1.4M in total revenue in fiscal year 2023. Revenue grew 9% year-over-year, indicating healthy expansion. The organization ran a surplus of $570K, a strong 41% operating margin.

Mission

P.U.N.T. Pediatric Cancer Collaborative provides families in Western New York facing pediatric cancer with critical programs that provide financial, practical and emotional support from diagnosis to recovery and bereavement. P.U.N.T. serves in collaboration with medical social workers and psychologists to ensure every dollar raised gets channeled directly where it is needed.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,184,586

Program Service Revenue $25,384

Investment Income $37,445

Other Revenue $142,488

TOTAL REVENUE $1,389,903

Expense Breakdown

Grants Paid $164,675

Salaries & Benefits $361,342

Fundraising Expenses $257,697

Program Expenses $437,729

Other Expenses $293,473

TOTAL EXPENSES $819,490

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,389,903	$1,276,900	+0.1%
Expenses	$819,490	$548,018	+0.5%
Net Income	$570,413	$728,882	-0.2%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$127,263

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GWEN MYSIAK	Executive Dir.	40.00	Officer	$127,263	$0	$127,263
RACHEL IRELAND	Director	3.00	Director	$0	$0	$0
MARY KAMIEN	Director	3.00	Director	$0	$0	$0
COLEEN MCCANN	Chairman	3.00	Officer Director	$0	$0	$0
JOHN FLANNERY	Vice Chair	3.00	Officer Director	$0	$0	$0
JULIE RODO	Director	3.00	Director	$0	$0	$0
MARY SUTO	Director	3.00	Director	$0	$0	$0
MARCY MUNSON	Director	3.00	Director	$0	$0	$0
MEGHAN HESS	Director	3.00	Director	$0	$0	$0
TERRIE CARBONE	Secretary	3.00	Officer Director	$0	$0	$0
CLAUDINE EWING	Director	3.00	Director	$0	$0	$0
JIM FASHANO	Director	3.00	Director	$0	$0	$0
JOHN LUDTKA	Treasurer/Direc	3.00	Officer Director	$0	$0	$0
DR MARTIN BRECHER	Director	3.00	Director	$0	$0	$0
TIMOTHY DOMINO	Treasurer	3.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,389,903	$819,490	$1,942,879	$570,413
2021	$548,379	$327,708	$451,684	$220,671
2021	$162,746	$83,181	$526,390	$79,565
2019	$246,476	$87,928	$268,373	$158,548

PUNT PEDIATRIC CANCER COLLABORATIVE INC